the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Nearly 10 mln pounds of meat recalled in US for listeria contamination

HOUSTON: Nearly 10 million pounds of meat and poultry products made at a plant in the central US state of Oklahoma have been recalled due to the possible contamination of listeria bacteria, which killed about 260 people each year in the country, local media reported on Thursday, said Xinhua.

The recall by BrucePac, a company headquartered in Woodburn, Oregon, includes 75 meat and chicken products produced between June 19 and Oct 8 at its facility in Durant, Oklahoma and sold nationwide. The products’ best-by date is from June 19, 2025 to Oct 8, 2025.

Earlier this week, US Department of Agriculture (USDA) detected listeria in samples of poultry during routine testing and identified BrucePac’s ready-to-eat chicken as the source in further tests.

“Restaurants, institutions, and other establishments are urged not to serve or use these products.

These products should be thrown away or returned to the place of purchase,“ the USDA said on Wednesday.

Listeria bacteria can cause listeriosis, which is the third leading cause of death from foodborne illness in the United States. Data from the US Centres for Disease Control and Prevention show that each year there are roughly 1,600 people infected with listeria bacteria in the country, with symptoms like fever, muscle aches and fatigue.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Addressing medical inflation

Consumers are struggling as medical insurance premiums surge, with over 340,000 dropping coverage amid calls for price regulation and stronger public healthcare

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings